Clinuvel Pharmaceuticals has outlined its commitment to corporate governance and remuneration policies, emphasizing the importance of acting ethically and responsibly. The company’s policies aim to safeguard the integrity of corporate reporting, make timely and balanced disclosures, and manage risks effectively.
Material actions and disclosures
Clinuvel has committed to adopting corporate governance policies to achieve the objectives of acting ethically and responsibly. The company’s policies and governance practices are listed under the eight Principles of Good Corporate Governance established by the ASX Corporate Governance Council. These include principles such as laying solid foundations for management and oversight, instilling a culture of acting lawfully, ethically, and responsibly, and safeguarding the integrity of corporate reports.
The company’s Corporate Governance Protocol and annual Corporate Governance Statement set out the code of conduct, including the Board Charter, Audit & Risk Committee Charter, Remuneration Committee Charter, Nomination Committee Charter, and Commercial Committee Charter. Additionally, policies such as the Code of Conduct and Ethics, Whistleblower Policy, and Anti-Bribery and Corruption Policy are in place to ensure integrity and ethical behavior.
Forward commitments
Clinuvel aims to continue enhancing its governance practices and remuneration policies to align with the fiduciary duties of the Board and the best interests of shareholders and stakeholders. The company plans to benchmark remuneration levels and structures against relevant international peers and consider global employment market conditions.
Furthermore, Clinuvel has committed to addressing the concerns raised by shareholders regarding the remuneration report. The company will engage with proxy advisors and investors to explain its approach and rationale for executive remuneration, aiming to align remuneration with performance and shareholder interests.
These measures reflect Clinuvel’s ongoing commitment to good corporate governance and responsible management practices.